Comparison of maternal and neonatal outcomes with epidural bupivacaine plus fentanyl and ropivacaine plus fentanyl for labor analgesia
Özet
Background: Several studies have been performed to find a safe method of labor analgesia with minimal side effects and toxicity in mother and fetus We aimed to compare the efficacy and side effects of epidural bupivacaine plus fentanyl and ropivacame plus fentanyl at low concentrations. Method: Forty ASA I-II parturients' were included in this prospective, double-blind, trial and randomized to receive either bupivacaine or ropivacame for labor analgesia Analgesia was initiated with 8 mL of 0.125% solution plus fentanyl 50 mu g and maintained with a continuous infusion of 0.0625% solution with fentanyl 2 mu g/mL. Results: There were no differences in pain scores, total dose of local anesthetics used, sensory or motor blockade, labor duration, mode of delivery, side effects, patient satisfaction, or neonatal outcome between the two local anesthetics at these dosages, but at the end of the second stage and delivery, adequate analgesia quality could not be ensured. Conclusion: We found no major advantage of continuous epidural infusion of ropivacame 00625% plus fentanyl 2 mu g/mL over bupivacaine 0.0625% plus fentanyl 2 mu g/mL for labor analgesia. We believe that different methods or dosages may be tried in order to improve comfort at the second stage of labor and the delivery. (c) 2005 Elsevier Ltd. All rights reserved.
